10 Best AI Driven Biotech Stocks to Invest In
In this article, we will take a look at some of the best AI driven biotech stocks that are currently offering attractive upside potential.
Denali Therapeutics Inc. (DNLI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Holocene Advisors Brandon Haley | 3,905,225 | $100,442,387 | +23% | 0.23% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 3,734,336 | $96,047,122 | +1% | 0.48% |
| 3. | Fisher Asset Management Ken Fisher | 2,414,162 | $62,092,245 | -1% | 0.02% |
| 4. | Casdin Capital Eli Casdin | 2,045,000 | $52,597,400 | +12% | 2.63% |
| 5. | Siren L.L.C. Raymond Debbane | 1,396,513 | $35,918,314 | 0.73% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 275,000 | $4,950,000.00 | 19,462,499 | 2017-12-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.74 | 615 | $14,600.10 | 19,686 | 2026-09-02 | Filing | |
| $22.85 | 10,824 | $247,328.40 | 20,301 | 2026-09-02 | Filing | |
| $23.44 | 2,768 | $64,881.92 | 278,995 | 2026-09-01 | Filing | |
| $25.07 | 2,857 | $71,624.99 | 281,763 | 2026-08-11 | Filing | |
| $16.50 | 35,198 | $580,767.00 | 296,833 | 2026-01-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,026,413 | $360,759,342 | 0.01% | |
| 2. | 11,960,230 | $307,617,116 | 0.28% | |
| 3. | 7,049,304 | $181,308,099 | 0.01% | |
| 4. | 7,012,974 | $180,373,691 | 0.48% | |
| 5. | 6,477,057 | $166,589,906 | 0.01% |
News See All
Jeff Bezos Stock Portfolio: Top 10 Stock Picks
In this article, we discuss the Jeff Bezos Stock Portfolio: Top 10 Stock Picks.
10 Best Biotech Stocks with Highest Upside Potential
In this article, we will take a look at some of the best biotech stocks that are currently offering attractive upside to investors. On April 16, reports from J.P.
Is Denali Therapeutics (DNLI) the Most Promising Mid-Cap Healthcare Stock Under $50?
Denali Therapeutics (NASDAQ:DNLI) is one of the most promising mid-cap healthcare stocks under $50.
15 Most Promising Mid-Cap Healthcare Stocks Under $50
Traditionally, healthcare stocks have been considered defensive, offering strong immunity to business cycles.
H.C. Wainwright Reiterates “Buy” Rating on Denali Therapeutics (DNLI) With $32 PT Following Q3 Results
Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the 15 stocks set to explode in 2026. On November 7, 2025, H.C. Wainwright’s Andrew Fein reiterated his “Buy” rating on Denali Therapeutics Inc.
15 Stocks Set to Explode in 2026
In this article, we discuss the 15 stocks set to explode in 2026.
Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy
We recently compiled a list of 11 Best Future Stocks to Buy Now. Denali Therapeutics Inc. stands sixth on our list among the best future stocks. Denali Therapeutics Inc.
11 Best Future Stocks to Buy Now
In this article, we will be taking a look at the 11 best future stocks to buy now.
12 Oversold NASDAQ Stocks to Buy Now
In this article, we will look at the 12 Oversold NASDAQ Stocks to Buy Now.
Hedge Fund Resource Center